X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15013) 15013
Magazine Article (53) 53
Book / eBook (10) 10
Book Chapter (8) 8
Book Review (3) 3
Conference Proceeding (3) 3
Dissertation (3) 3
Newsletter (2) 2
Publication (2) 2
Web Resource (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10855) 10855
imidazoles - therapeutic use (9088) 9088
male (6910) 6910
female (5782) 5782
animals (5360) 5360
imidazoles - pharmacology (4685) 4685
middle aged (3803) 3803
adult (3121) 3121
aged (2781) 2781
imidazoles - administration & dosage (2644) 2644
pharmacology & pharmacy (2101) 2101
imidazoles - adverse effects (2018) 2018
mice (1911) 1911
rats (1905) 1905
oncology (1779) 1779
treatment outcome (1559) 1559
diphosphonates - therapeutic use (1516) 1516
cancer (1123) 1123
dose-response relationship, drug (1087) 1087
zoledronic acid (1045) 1045
bone density conservation agents - therapeutic use (990) 990
hypertension - drug therapy (962) 962
antineoplastic agents - therapeutic use (952) 952
cell line, tumor (933) 933
time factors (931) 931
drug therapy, combination (926) 926
adolescent (904) 904
analysis (898) 898
double-blind method (896) 896
apoptosis (894) 894
clinical trials as topic (879) 879
antihypertensive agents - therapeutic use (837) 837
pyridines - pharmacology (827) 827
imidazoles - chemistry (826) 826
tetrazoles - therapeutic use (784) 784
research (782) 782
aged, 80 and over (763) 763
blood pressure - drug effects (760) 760
care and treatment (755) 755
antifungal agents - therapeutic use (742) 742
disease models, animal (728) 728
drug therapy (715) 715
piperazines - therapeutic use (715) 715
expression (698) 698
therapy (677) 677
double-blind (634) 634
medicine & public health (631) 631
bone neoplasms - secondary (630) 630
biochemistry & molecular biology (621) 621
health aspects (617) 617
apoptosis - drug effects (616) 616
bisphosphonates (604) 604
cell biology (602) 602
imidazoles - pharmacokinetics (592) 592
rats, sprague-dawley (592) 592
administration, oral (586) 586
inhibition (563) 563
hypertension (558) 558
diphosphonates - administration & dosage (548) 548
proteins (548) 548
imidazole (535) 535
activation (524) 524
research article (520) 520
efficacy (516) 516
bone neoplasms - drug therapy (509) 509
antineoplastic agents - pharmacology (504) 504
in-vitro (501) 501
cell proliferation - drug effects (491) 491
diphosphonates - adverse effects (481) 481
imidazoles (478) 478
endocrinology & metabolism (475) 475
chemistry, medicinal (474) 474
cells, cultured (473) 473
chemotherapy (468) 468
medicine (466) 466
child (463) 463
diphosphonates - pharmacology (457) 457
kinases (456) 456
vardenafil dihydrochloride (455) 455
dogs (454) 454
antineoplastic combined chemotherapy protocols - therapeutic use (451) 451
mutation (449) 449
urology & nephrology (447) 447
cells (443) 443
medicine, general & internal (443) 443
enzyme inhibitors - pharmacology (440) 440
prospective studies (437) 437
neurosciences (435) 435
risk factors (433) 433
drug administration schedule (431) 431
multidisciplinary sciences (416) 416
follow-up studies (409) 409
imidazolidines (409) 409
metastasis (407) 407
phosphorylation (402) 402
osteoporosis (397) 397
pharmacology (395) 395
signal transduction - drug effects (395) 395
pharmacology/toxicology (393) 393
rats, wistar (392) 392
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13476) 13476
German (547) 547
French (266) 266
Japanese (257) 257
Russian (206) 206
Italian (164) 164
Spanish (109) 109
Chinese (68) 68
Polish (50) 50
Portuguese (47) 47
Danish (22) 22
Hungarian (21) 21
Czech (19) 19
Dutch (19) 19
Bulgarian (8) 8
Norwegian (7) 7
Slovak (6) 6
Hebrew (5) 5
Swedish (4) 4
Turkish (4) 4
Finnish (3) 3
Romanian (3) 3
Croatian (2) 2
Lithuanian (2) 2
Serbian (2) 2
Ukrainian (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European urology, ISSN 0302-2838, 2017, Volume 71, Issue 3, pp. 426 - 436
...), the most effective therapeutic approach for patients with non-clear cell RCC (non-ccRCC) is unknown. Objective To systematically review relevant literature comparing... 
Urology | Papillary | Systematic review | Sunitinib | Non-clear cell renal cell carcinoma | Everolimus | Chromophobe | carcinoma | Review | Non-clear cell renal cell | Journal Article | UROLOGY & NEPHROLOGY | PHASE-II | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Bevacizumab - therapeutic use | Humans | Interleukin-2 - therapeutic use | Antineoplastic Agents - therapeutic use | Interferons - therapeutic use | Comparative Effectiveness Research | Quinolones - therapeutic use | Everolimus - therapeutic use | Imidazoles - therapeutic use | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Carcinoma, Renal Cell - pathology | Pyrrolidinones - therapeutic use | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Disease-Free Survival | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Indoles - therapeutic use | Kidney Neoplasms - pathology | Erlotinib Hydrochloride - therapeutic use | Quinolines - therapeutic use | Kidney Neoplasms - drug therapy | Indazoles - therapeutic use | Medical colleges | Care and treatment | Carcinoma, Renal cell | Endothelial growth factors | Analysis | Endothelium | Urologi och njurmedicin | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Cancer and Oncology | Urology and Nephrology | Cancer och onkologi
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2011, Volume 2013, Issue 1, p. CD006626
Journal Article
Head & Neck, ISSN 1043-3074, 05/2012, Volume 34, Issue 5, pp. 736 - 745
The incidence of thyroid cancer continues to increase and this neoplasia remains the most common endocrine malignancy. No effective systemic treatment... 
epidermal growth factor (EGF) | RET | immunomodulator | vascular disrupting agent | multi‐kinase inhibitor | vascular endothelial growth factor (VEGF) | thyroid cancer | histone acetylation | B‐Raf | heat shock protein (HSP) | multi-kinase inhibitor | B-Raf | SURGERY | HISTONE DEACETYLASE INHIBITOR | SUBEROYLANILIDE HYDROXAMIC ACID | ABL TYROSINE KINASE | PROTEASOME INHIBITION | CELL-CYCLE ARREST | VALPROIC ACID | DEPSIPEPTIDE FR901228 | PHASE-II TRIAL | OTORHINOLARYNGOLOGY | IMATINIB MESYLATE | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Bibenzyls - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | Thalidomide - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Valproic Acid - therapeutic use | Depsipeptides - therapeutic use | Imidazoles - therapeutic use | Lactams, Macrocyclic - therapeutic use | Pyrroles - therapeutic use | Pyridines - therapeutic use | Bortezomib | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Piperazines - therapeutic use | Imatinib Mesylate | Sulfonamides - therapeutic use | Thyroid Neoplasms - drug therapy | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Hydroxamic Acids - therapeutic use | Indoles - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Quinolines - therapeutic use | Benzamides | Thalidomide - therapeutic use | Benzoquinones - therapeutic use | Indazoles - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 50, pp. 109 - 117
... are approved for first-line or later-line use in the treatment of patients with mRCC [1–3] . Among these agents, 1 is a monoclonal antibody targeting vascular endothelial... 
Hematology, Oncology and Palliative Medicine | Prognostic markers | Predictive markers | Sequential therapy | Overall survival | Targeted therapy | mRCC | PROGRESSION-FREE SURVIVAL | 1ST-LINE SUNITINIB | BLIND PHASE-III | OPEN-LABEL | INTERFERON-ALPHA | ONCOLOGY | 2ND-LINE TREATMENT | EXPRESSION LEVELS | CANCER-SPECIFIC SURVIVAL | CLINICAL-PRACTICE | DOSE TITRATION | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Kidney Neoplasms - genetics | Bevacizumab - therapeutic use | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Carcinoma, Renal Cell - genetics | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - metabolism | Vascular Endothelial Growth Factor A - genetics | Sunitinib | Tumor Suppressor Proteins - genetics | Biomarkers, Tumor - metabolism | Axitinib | Everolimus - therapeutic use | Von Hippel-Lindau Tumor Suppressor Protein - genetics | Imidazoles - therapeutic use | Carcinoma, Renal Cell - drug therapy | Nuclear Proteins - genetics | Pyrroles - therapeutic use | Molecular Targeted Therapy - methods | Pyridines - therapeutic use | Histone-Lysine N-Methyltransferase - genetics | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Receptors, CCR4 - genetics | Interferon-alpha - therapeutic use | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Transcription Factors - genetics | Ubiquitin Thiolesterase - genetics | Carcinoma, Renal Cell - metabolism | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Nivolumab | Sorafenib | Indoles - therapeutic use | Kidney Neoplasms - pathology | MicroRNAs - genetics | Quinolines - therapeutic use | Mutation | Kidney Neoplasms - drug therapy | Indazoles - therapeutic use | Precision Medicine - methods | Immunologic Factors - therapeutic use | Antimitotic agents | Care and treatment | Metastasis | Antineoplastic agents | Patient outcomes | Cancer
Journal Article
Liver international, ISSN 1478-3223, 2016, Volume 36, Issue S1, pp. 47 - 57
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 03/2018, Volume 2018, Issue 3, p. CD011481
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 61 - 73
Journal Article